Ignite Creation Date:
2024-05-05 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232596
Status:
COMPLETED
Last Update Posted:
2016-12-08
First Post:
2005-09-30
Brief Title:
Retigabine Adjunctive Therapy Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
Sponsor:
Organization:
GlaxoSmithKline